CRISPR

February 7, 2019

New information is unfolding on the genetic controls of an early turning point in pregnancy.

September 14, 2018

An analysis of nearly 4,000 mutations deliberately engineered into the BRCA1 gene will immediately benefit people undergoing genetic testing for breast or ovarian cancer risk.

September 12, 2018

A new scientific analysis of nearly 4,000 mutations deliberately engineered into the BRCA1 gene will immediately benefit people undergoing genetic testing for breast or ovarian cancer risk.

Subscribe to CRISPR